β-Adrenoceptor polymorphisms

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 369, Issue 1, 2004, Pages 1-22

  Leineweber, K ^a   Buscher R ^a   Bruck, H ^a   Brodde, O E ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

Author keywords

Adrenoceptors; Genotype; Haplotype; Linkage disequilibrium; Phenotype; Single nucleotide polymorphism

Indexed keywords

4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 [2 [[2 (3 CHLOROPHENYL) 2 HYDROXYETHYL]AMINO]PROPYL]PHENOXYACETIC ACID; ADRENALIN; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 3 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR STIMULATING AGENT; BISOPROLOL; BRL 37 344; BRONCHODILATING AGENT; CGP 12177 A; CL 316243 5; DOBUTAMINE; ISOPRENALINE; L 755 507; METOPROLOL; NORADRENALIN; SALBUTAMOL; TERBUTALINE;

ALLELE; AMINO ACID SUBSTITUTION; ASTHMA; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; DRUG POTENCY; DRUG RECEPTOR BINDING; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HAPLOTYPE; HEART MUSCLE CONTRACTILITY; HEART RATE; HUMAN; HYPERTENSION; INOTROPISM; INTESTINE MOTILITY; MORTALITY; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHENOTYPE; REVIEW; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; VASODILATATION;

ANIMALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3;

EID: 0742269427     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0824-2     Document Type: Review

References (170)

1. Allison DB, Heo M, Faith MS, Pietrobelli A (1998) Meta-analysis of the association of the Trp64Arg polymorphism in the β3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 22:559-566
2. 3- adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Pharmacol Ther 12:519-525
3. Arch JR, Ainsworth AT, Cawthorne MA, Piercy V, Sennitt MV, Thody VE, Wilson C, Wilson S (1984) Atypical adrenoceptor on brown adipocytes as target for anti-obesity drugs. Nature 309:163-165
4. Arner P, Hoffstedt J (1999) Adrenoceptor genes in human obesity. J Intern Med 245:667-672
5. 2-adrenergic receptor among Turks. Brit J Clin Pharmacol 48:761-764
6. Aziz I, Hall IP, McFarlane LC, Lipworth BJ (1998) Beta 2-adrenoceptor regulation and bronchodilator sensitivity after regular treatment with formoterol in subjects with stable asthma. J Allergy Clin Immunol 101:337-341
7. 3-adrenergic receptor gene polymorphism is not associated with hypertension in NIDDM patients without nephropathy. Horm Metab Res 30: 629-632
8. Barbato E, Penicka M, Delrue L, Vanderheyden M, Wijns, Heyndrickx G, Goethals M, De Bruyne B, Bartunek J (2002) Genetic modulation of human cardiac performance by Ile-164 polymorphism of beta-2 adrenergic receptor. Circulation 106 No 19 (Suppl II):327-328
9. 1- adrenergic receptor gene and hypertension. Circulation 104: 187-190
10. 2-Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 37:1303-1308
11. 3-adrenoceptor mRNA in human tissue. Eur J Pharmacol 289:223-228
12. 1-adrenergic receptor associated with survival in patients with heart failure. Eur Heart J 21:1853-1858
13. 2- adrenergic receptor gene as susceptible locus for human hypertension. Circulation 101:2877-2882
14. 2- adrenoceptors in the human heart: properties, function, and alterations in heart failure. Pharmacol Rev 43:203-242
15. Brodde O-E, Michel MC (1999) Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev 51:651-689
16. 2-adrenoceptors. Circulation 103:1048-1050
17. 2-adrenoceptor polymorphism slows the onset of desensitization of cardiac functional responses in vivo. Pharmacogenetics 13:59-66
18. 2- adrenoceptor exhibits blunted desensitization of cardiac functional responses in vivo. Am J Physiol Heart Circ Physiol 285:H2034-H2038
19. 2-adrenergic receptor down-regulation. Clin Pharmacol Ther 74:255-263
20. 1- adrenoceptor polymorphism in humans. Pharmacogenetics 11:199-205
21. 2 Adrenoceptor gene polymorphisms in cystic fibrosis lung disease. Pharmacogenetics 12: 347-353
22. 2- Adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension 35:555-560
23. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U (1994) IV. International Union of Pharmacology: nomenclature of adrenoceptors. Pharmacol Rev 46:212-136
24. 3-adrenergic receptor mutant. Endocrinology 137:2638-2641
25. 2 adrenoceptor polymorphisms with hypertension in a Black African population. J Hypertens 18:167-172
26. 3-(Trp64Arg)- adrenoceptor genes are associated with elevated serum NEFA concentrations and Type II diabetes. Diabetologia 44:629-636
27. 3- adrenoceptor in human adipose tissue, atrium and skeletal muscle. Int J Obes Relat Metab Disord 23:1057-1065
28. Charon C, Dupuy F, Marie V, Bazin R (1995a) Effect of the β-adrenoceptor agonist BRL-35135 on development of obesity in suckling Zucker (fa/fa) rats. Am J Physiol 268:E1039-E1045
29. 3-adrenoceptor activities. Biochem J 312:781-788
30. 3-adrenergic receptor gene with obesity in patients with type 2 diabetes mellitus. Zhonghua Yu Fang Yi Xue Za Zhi 35:333-335
31. 2-adrenoceptor on desensitisation in human lung mast cells. Pharmacogenetics 10: 153-162
32. 3 receptor gene impairs insulin secretion: a twin study. Diabet Med 16:835-840
33. 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352-354
34. 2-Adrenoceptor polymorphism determines vascular reactivity in humans. Hypertension 36:371-375
35. Collins S, Daniel KW, Rohlfs EM (1999) Depressed expression of adipocyte β-adrenergic receptors is a common feature of congenital and diet-induced obesity in rodents. Int J Obes Relat Metab Disord 23:669-677
36. 2-adrenoceptor (ADRB2) haplotypes. Am J Respir Crit Care Med 158:1968-1973
37. 2-adrenoceptor polymorphisms and enhanced IgE responsiveness in an atopic population. Clin Exp All 29:794-799
38. 2 adrenoceptor polymorphism is associated with elevated immunglobulin E levels in asthmatic families. J Allergy Clin Immunol 100:261-265
39. 2 Adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population. Clin Exp All 28:442-448
40. Dishy V, Sofowora G, Xie HG, Harris P, Wood AJJ Stein CM (2001a) Arg389Gly beta-1 adrenoceptor polymorphism does not affect agonist-mediated responses in vivo (abstract). Clin Pharmacol Ther 69:P5
41. Dishy V, Sofowora GG, Xie HG, Kim RB, Byrne DW, Stein CM, Wood AJ (2001b) The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. N Engl J Med 345:1030-1035
42. 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc Natl Acad Sci USA 97:10483-10488
43. Echwald SM, Sorensen TI, Tybjaerg-Hansen A, Andersen T, Pedersen O (1998) Gln27Glu variant of the human beta2-adrenoceptor gene is not associated with early-onset obesity in Danish men. Diabetes 47:1657-1658
44. 3-adrenergic receptor. Science 245: 1118-1121
45. 3-adrenoceptor mRNA in rat tissues. Br J Pharmacol 117:210-216
46. Fenech A, Hall IP (2001) Pharmacogenetics of asthma. Br J Clin Pharmacol 53:3-15
47. 1-adrenergic receptor. Proc Natl Acad Sci USA 84:7920-7924
48. 3-adrenergic receptor in essential hypertension: insulin resistance and the adrenergic system. Am J Hypertens 10:101-105
49. 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 83:2441-2444
50. 2-Adrenergic receptor polymorphism and nitric oxide-dependent forearm blood flow responses to isoproterenol in humans. J Physiol (Lond) 546:583-589
51. 3-adrenoceptor in the human heart. J Clin Invest 98:556-562
52. 3- Adrenoceptors in the cardiovascular system. Trends Pharmacol Sci 21:426-431
53. Granneman JG (1995) Expression of adenylyl cyclase subtypes in brown adipose tissue: neuronal regulation of type III. Endocrinol 136:2007-2012
54. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe MR, Skrabal F (1999) Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33:1425-1430
55. 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268:23116-23121
56. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414-9419
57. 2-adrenergic receptor structure. Pulm Pharmacol 8:1-10
58. 2-adrenergic receptor genotype on signal transduction in human airway muscle cells. Am J Respir Cell Mol Biol 13: 25-33
59. s. Eur J Pharmacol 421:141-147
60. 3-adrenergic receptor. Eur J Biochem 224:761-770
61. 2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects. Lancet 345:1213-1214
62. 2-agonist therapy in asthma. Eur Respir J 100:3184-3188
63. 1- adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. Pharmacogenetics 11:191-197
64. 2-Adrenergic receptor polymorphism and risk of incident cardiovascular events in the elderly. Circulation 107:2021-2024
65. Hellstrom L, Large V, Reynisdottir S, Wahrenberg H, Arner P (1999) The different effects of a Gln27Glu beta 2-adrenoceptor gene polymorphism on obesity in males and females. J Intern Med 245:253-259
66. 2-Adrenergic receptor polymorphisms at codon 16, cardiovascular phenotypes and essential hypertension in Whites and African Americans. Am J Hypertens 13:1021-1026
67. 3-adrenergic receptor gene with coronary heart disease among Japanese. Biochem Biophys Res Commun 232:728-730
68. 3- adrenoceptor gene forms a well-conserved haplotype that is associated with moderate obesity and altered receptor function. Diabetes 48:203-205
69. 2 adrenoceptor gene Thr164Ile polymorphism on human adipose tissue lipolytic function. Br J Pharmacol 133:708-712
70. Hoit BD, Suresh DP, Craft L, Walsh RA, Liggett SB (2000) Beta2-adrenergic receptor polymorphisms at amino acid 16 differentially influence agonist-stimulated blood pressure and peripheral blood flow in normal individuals. Am Heart J 139: 537-542
71. Hollenga C, Zaagsma J (1989) Direct evidence for the atypical nature of functional β-adrenoceptors in rat adipocytes. Br J Pharmacol 98:1420-1424
72. 2- adrenoceptor with reported childhood asthma: population based study. Br Med J 316:664
73. 1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. Am J Cardiol 88:1034-1037
74. Ikegami H, Yamato E, Fujisawa T, Hamada Y, Fujioka Y, Rakugi H, Higaki J, Murakami H, Shimamoto K, Ogihara T (1996) Analysis of candidate genes for insulin resistance in essential hypertension. Hypertens Res 19:S31-S34
75. 3-adrenergic receptor gene in patients with type 2 diabetes mellitus - a study using a pin-point sequencing method. Exp Clin Endocrinol Diabetes 109:386-368
76. Ishiyama-Shigemoto S, Yamada K, Yuan X, Ichikawa F, Nonaka K (1999) Association of polymorphisms in the beta2-adrenergic gene with obesity, hypertriglyceridaemia, and diabetes mellitus. Diabetologia 42:98-101
77. Isogaya M, Nagao T, Kurose H (2002) Enhanced cAMP response of naturally occuring mutant of human b3-adrenergic receptor. Jpn J Pharmacol 88:314-318
78. Iwai C, Akita H, Shiga N, Takai E, Miyamoto Y, Shimizu M, Kawai H, Takarada A, Kajiya T, Yokoyama M (2002) Suppressive effect of the Gly389 allele of the beta1-adrenergic receptor gene on the occurrence of ventricular tachycardia in dilated cardiomyopathy. Circ J 66:723-728
79. 3-adrenergic receptor and glucose tolerance in the Dutch population. Clin Endocrinol 49:229-234
80. Johnson JA, Terra SG (2002) β-Adrenergic receptor polymorphisms: cardiovascular disease associations and pharmacogenetics. Pharm Res 19:1779-1787
81. 1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 74:44-52
82. Joos L, Sandford AJ (2002) Genotype predictors of response to asthma medications. Curr Opin Pulm Med 8:9-15
83. Kanki H, Yang P, Xie HG, Kim RB, George AL Jr, Roden DM (2002) Polymorphisms in beta-adrenergic receptor genes in the acquired long QT syndrome. J Cardiovasc Electrophysiol 13: 252-256
84. 2-adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 37:286-292
85. Kaumann AJ, Molenaar P (1997) Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn-Schmiedeberg's Arch Pharmacol 355:667-681
86. 4-adrenoceptor pharmacology. Naunyn-Schmiedeberg's Arch Pharmacol 363:87-93
87. 2-adrenoceptor on the effects of β-adrenoceptor agonists on human lung mast cells. Int Immunopharmacol 3:91-95
88. 3-adrenergic agonists in transfected 3T3-L1 pre-adipocytes. Horm Metab Res 32:91-96
89. 3 adrenergic receptor agonist, (S)-(Z)-[4-[[1-[2-[(2-hydroxy-3-phenoxypropyl)] amino]ethyl]-1-propenyl] phenoxy] acetic acid ethanedioic acid (SWR-0342SA), in KK-Ay mice. Biol Pharm Bull 22:1073-1078
90. Kobilka BK, Dixon RA, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng Francke U, Caron MG, Lefkowitz RJ (1987) cDNA for the human beta 2-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 84:46-50
91. Kortner B, Wolf A, Wendt D, Beisigel U, Evans D (1999) Lack of association between a human beta-2-adrenoceptor gene polymorphism (gln27glu) and morbid obesity. Int J Obes Relat Metab Disord 23:1099-1100
92. 2-adrenoceptor. Hypertension 30:773-776
93. 3-adrenergic receptor mRNA in man. J Clin Invest 91:344-349
94. 3-adrenergic receptor gene Trp64Arg mutation is overrepresented in obese women. Effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 45:1358-1363
95. Large V, Hellström L, Reynisdottir S, Lönnqvist F, Eriksson P, Lannfelt L, Arner P (1997) Human beta-2 adrenoceptor gene polymorphisms are highly frequent in obesity and associate with altered beta-2 adrenoceptor function. J Clin Invest 100: 3005-3013
96. 1-Adrenozeptors: Unterschiedliche Effekte von Metoprolol in Abhängigkeit vom Genotyp (abstract). Z Kardiol 92 (Suppl):I/191
97. 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation. J Biol Chem 277:30429-30435
98. 3- adrenergic receptor gene in normal weight and obese subjects. Diabetologia 39:857-860
99. 2-adrenergic receptor polymorphisms. News Physiol Sci 10:265-273
100. 2-adrenergic receptor and asthma. Am J Respir Crit Care Med 156:S156-162
101. 2-adrenergic receptor polymorphisms adversely affects the outcome of congestive heart failure. J Clin Invest 102:1534-1539
102. 2- adrenoceptors in asthmatic patients. Chest 115:324-328
103. 2-Adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells. Thorax 57:61-66
104. 1-adrenoceptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 74:372-379
105. 3-adrenoceptor in man. Br J Pharmacol 110:929-936
106. 1-adrenoceptor: identification and rapid screening assay. Lancet 353:897
107. 3-adrenoceptors and airways. Fundam Clin Pharmacol 9:114-118
108. 2-adrenoceptor and response to albuterol in children with and without a history of wheezing. J Clin Invest 100:3184-3188
109. 1-adrenergic receptor. J Biol Chem 274:12670-12674
110. McDevitt DG (1989) In vivo studies on the function of cardiac β-adrenoceptors in man. Eur Heart J 10 (Suppl. B):22-28
111. McGraw DW, Forbes SL, Kramer LA, Liggett SB (1998) Polymorphisms of the 5′-leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 102: 1927-1932
112. 3-adrenergic receptor amino acid variant confers increased sensitivity to the pressor effects of noradrenaline in Sardinian subjects. Clin Sci 103:397-402
113. 1-adrenergic receptor polymorphisms in human right atrium in vitro. J Am Coll Cardiol 40:1275-1282
114. 1-adrenergic receptor polymorphisms: analysis of c145A→G and c1165G→C (abstract). Human Mutation 14:271
115. 2-adrenergic receptor gene and desensitisation in human airway smooth muscle. Am J Respir Crit Care Med 162:2117-2124
116. Mori Y, Kim-Motoyama H, Ito Y, Katakura T, Yasuda K, Ishiyama-Shigemoto S, Yamada K, Akanuma Y, Ohashi Y, Kimura S, Yazaki Y, Kadowaki T (1999) The Gln27Glu beta2-adrenergic receptor variant is associated with obesity due to subcutaneous fat accumulation in Japanese men. Biochem Biophys Res Commun 258:138-140
117. 2-adrenoceptor. Eur J Pharmacol 457:1-10
118. 1-adrenoceptor does not influence blood pressure or heart rate response to β-blockade in hypertensive subjects. Clin Sci 99:233-238
119. Parola AL, Kobilka BK (1994) The peptide product of a 5′-leader cistron in the beta 2 adrenergic receptor mRNA inhibits receptor synthesis. J Biol Chem 269:4497-4505
120. 3-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 27:133-144
121. 3-adrenoceptor activity. Eur J Biochem 247:1174-1179
122. 3-adrenergic receptor gene and the promoter variant (A-3826G) of the uncoupling protein 1 gene in familial combined hyperlipidemia. Metabolism 47:1397-1402
123. 1-Adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? J Mol Med 78:87-93
124. 2-adrenoceptor-mediated positive inotropic effects: attenuation by ketotifen. Cardiovasc Res 40:211-222
125. 3-adrenergic agonists in isolated human fat cells from omental and retroperitoneal adipose tissues. Rev Esp Fisiol 51:193-200
126. 3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients. Metabolism 48:853-856
127. 1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70: 935-942
128. 1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39: 155-160
129. 2-adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 8:334-339
130. Ruffolo RR Jr, Spradlin TA, Pollock GD, Waddell JE, Murphy PJ (1981) Alpha and beta adrenergic effects of the stereoisomers of dobutamine. J Pharmacol Exp Ther 219:447-452
131. 1-adrenergic receptor gene polymorphism and human fat cell lipolysis. Int J Obes Relat Metab Disord 25:1599-1603
132. 1-adrenoceptors in isolated human atrial myocardium. Br J Pharmacol 138:386-392
133. 1-adrenoceptor. Naunyn-Schmiedeberg's Arch Pharmacol 367: 10-21
134. 2- adrenergic receptor gene. Br J Pharmacol 126:841-844
135. Shen YT, Zhang H, Vatner F (1994) Peripheral vascular effects of beta-3 adrenoceptor receptor stimulation in conscious dogs. J Pharmacol Exp Ther 268:466-473
136. 3-adrenergic receptor gene and insulin resistance in patients with coronary heart disease. Metabolism 48:651-654
137. 3-adrenergic receptor and autonomic nervous system activity. J Clin Endocrinol Metab 84:1623-627
138. 3-adrenergic receptor genes on autonomic nervous system activity. Int J Obes 25:761-766
139. 2c-adrenergic receptor. J Biol Chem 275:23059-23064
140. 2C- adrenergic receptors and the risk of congestive heart failure. N Engl J Med 347:1135-1142
141. 3-adrenoceptor variant on in vivo lipolysis in subcutaneous adipose tissue. Diabetologia 40:838-842
142. 1- adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β-blockade. Clin Pharmacol Ther 73:366-371
143. 3-adrenergic receptor Trp64Arg mutation is not associated with coronary artery disease. Metabolism 50:184-188
144. 3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens 19:399-406
145. 3-adrenoceptor polymorphism with obesity and diabetes: current status. Trends Pharmacol Sci 18:449-454
146. 2-Adrenergic receptor Arg16/Arg16 genotype is associated with reduced lung function, but not with asthma, in the Hutterites. Am J Respir Crit Care Med 162:599-602
147. 3-adrenergic receptor gene. J Biol Chem 270: 29483-29492
148. 3-adrenergic receptor gene and coronary atherosclerosis in Japanese subjects. Int J Cardiol 69: 309-311
149. 1-adrenoceptor gene and evaluation of its role in idiopathic dilated cardiomyopathy. J Mol Cell Cardiol 31:1025-1032
150. 3-adrenergic receptor mRNA expression in adipose and other metabolic tissues in the adult human. Mol Pharmacol 43:343-348
151. 3-adrenergic receptor gene and obesity in Chinese subjects with components of the metabolic syndrome. Int J Obes Relat Metab Disord 24: 545-551
152. 2-Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: the Bergen Blood Pressure Study. Kidney Int 53:1455-1460
153. 3-adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J Hypertens 17:33-38
154. 2-adrenergic receptor in nocturnal and non-nocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 95:1635-1641
155. 2-adrenergic receptor polymorphism expressed in transgenic mice. Proc Natl Acad Sci USA 93: 10483-10488
156. 2-adrenoceptor variants with bronchial hyperresponsiveness. Am J Respir Crit Care Med 161:469-474
157. 3-adrenoceptor agonist in human omental adipocytes. Diabetes 48:117-120
158. 3-adrenergic receptor gene. Diabetes 45:1115-1120
159. 3-adrenergic receptor gene and the -3826 A→G variant of the uncoupling protein-1 gene on features of obesity and insulin resistance in a population-based sample of 379 young Danish subjects. J Clin Endocrinol Metab 85:3151-3154
160. 2-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 86:834-840
161. 1-adrenergic receptor predict exercise capacity in heart failure. Am Heart J 144:840-846
162. 3-adrenergic-receptor gene. N Engl J Med 333:343-347
163. 2 Adrenergic receptor haplotypes in mild, moderate and fatal/ near fatal asthma. Am J Respir Crit Care Med 158:787-791
164. White HL, Maqbool A, McMahon AD, Yates L, Ball SG, Hall AS, Balmforth AJ (2002) An evaluation of the beta-1 adrenergic receptor ARg389Gly polymorphism in individuals at risk of coronary events. A WOSCOPS substudy. Eur Heart J 23:1087-1092
165. 3-adrenergic- receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348-351
166. Wilson C, Wilson S, Piercy V, Sennitt MV, Arch JR (1984) The rat lipolytic β-adrenoceptor: studies using novel β-adrenoceptor agonists. Eur J Pharmacol 100:309-319
167. 2-adrenergic receptor polymorphisms: no association with essential hypertension in black and white Americans. Clin Pharmacol Ther 67:670-675
168. t-adrenoceptor polymorphism varies in frequency among different ethic groups but does not alter response in vivo. Pharmacogenetics 11:191-197
169. 2-adrenergic receptor gene associated with obesity and type 2 diabetes. J Clin Endocrinol Metab 84:1754-1757
170. 3-adrenoceptor coupled to lipolysis. J Cell Sci 110:801-807